This award is intended to foster collaborative efforts between investigators from two or more Diabetes Research Centers (DRCs) and/or Centers for Diabetes Translational Research (CDTRs) at different institutions. For example, applications can be between two DRCs, two CDTRs or projects between a DRC and CDTR member investigators. However, a DRC and CDTR collaboration from the same institution is not allowed, unless another DRC or CDTR key collaboration is part of the application. The initial round of applications must be related to aspects of COVID-19 disease related to diabetes, obesity or metabolism at the basic, clinical or community levels.
Applications are due by March 1, 2022, with an anticipated review in March 2022 and project start date in April 2022. Funds are currently available for 1-year, but it is anticipated that additional funds will become available for a second year of funding. Awardees will be required to submit a progress report at the end of the first year of funding.
Eligibility requiremets:
- Investigators at all faculty levels are eligible to apply.
- Investigators must be current members of a DRC or CDTR as indicated by their inclusion on their centers membership web site.
Applications need to adhere to the following:
- Proposal must be no more than 5 pages in length (no smaller than Arial 11 font with 0.5 inch margins) including citations. Maximum of ½ page for specific aims, ½ page for significance, ½ page for leadership plan that indicates how the collaboration will facilitate the project, and 3 ½ pages for project description.
- There is no page limitation on references cited.
- Preliminary data can be included but are not required.
- Include a separate budget page using the provided form (maximum $100,000) and a budget justification – no more than 1 page.
- Provide NIH formatted biosketch for each principal investigator.
- Salary support for the multiple principal investigators is limited to $5,000 per principal investigator. Funds can be used for trainee and staff salaries, supplies, and any other costs associated with the project.
- A letter from each prinicipal investigators institutional official agreeing that they will waive indirect (F&A) costs for this award.
- Letters of support as appropriate for access to core or clinical facilities.
- Submit the application as a single PDF file by March 1, 2022 to Fran Taibi by Email fran.taibi@einsteinmed.edu